Announcements Trials
Browse Landscape

Phase

Phase 3 62Phase 2 59Phase NA 28Phase 1/2 6Phase 2/3 4Phase 1 3Phase EARLY_PHASE1 1

Status

Completed 16Terminated 7Unknown 5Active not recruiting 5Recruiting 4Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 154INDUSTRY 76OTHER_GOV 9NIH 7NETWORK 4FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 3Gynecologic 1

Conditions

Lung Neoplasms 2Previously Treated Non-Small Cell Lung Cancer 1Peritoneal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2pembrolizumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1cemiplimab 1auricularum 1Standard of Care 1Ramucirumab 1Practice Guidelines as Topic 1Laparoscopy 1Docetaxel 1Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × NETWORK × Clear all
NCT03851445 2026-05-18

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

SWOG Cancer Research Network

Phase 2/3 Recruiting
10,000 enrolled
Thoracic

Previously Treated Non-Small Cell Lung Cancer

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting
148 enrolled
Gynecologic

Peritoneal Neoplasms

NCT06616584 2026-05-05

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

SWOG Cancer Research Network

Phase 2/3 Recruiting
378 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04093167 2026-03-11

Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

Canadian Cancer Trials Group

Phase 2/3 Recruiting
230 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡